BDBM590844 6-cyclopropyl-1-(4-fluorobenzyl)-2-oxo- N-(spiro[3.3]heptan-2-yl)-1,2-dihydro-1,8- naphthyridine-3-carboxamide::US11564928, Compound 93

SMILES Fc1ccc(Cn2c3ncc(cc3cc(C(=O)NC3CC4(CCC4)C3)c2=O)C2CC2)cc1

InChI Key InChIKey=MDNQVWJNJSMQHY-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590844   

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590844(US11564928, Compound 93 | 6-cyclopropyl-1-(4-fluor...)
Affinity DataIC50: 3.60nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590844(US11564928, Compound 93 | 6-cyclopropyl-1-(4-fluor...)
Affinity DataIC50: 1.00E+4nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent